Ticker brief
DXCM DEXCOM INC
Consumer, Non-cyclical · Pharmaceuticals
last close
$77.94
1 day
-0.5%
14 days
-7.3%
mkt cap
$27.5B
signals 14d
9
authors 14d
8
crowd 14d
-0.3σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 48% mid · 57 pctile own 1y | IV/HV 1.53× |
| Skew — 25Δ RR 30d | +0.012 95 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | +0.33 elevated | 5-session Δ +0.14 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2025-10-31 (z=5.6) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-06 → 2026-10-16 · now +0.70 (−1 bearish … +1 bullish)
Who spoke8
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Briefingcom | B | -2.26 | 2 | +0.21 |
| @InvestVerified | C | +0.45 | 1 | +0.65 |
| @AryaFintech | C | -1.41 | 1 | -0.30 |
| @KeithTradeSmith | C | +1.08 | 1 | +0.50 |
| @OpenOutcrier | C | · | 1 | +0.35 |
| @ClassicRoy | C | -1.10 | 1 | +0.00 |
| @fj_nextstage | C | -2.23 | 1 | +0.25 |
| @d_pavlos | C | -0.43 | 1 | +0.70 |
Recent signals9of 9 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @d_pavlos | +0.70 | Buy 85.80 versus 82.60, or buy a close above 90.39. — Explicit long entries and invalidation level supported by wave and volume analysis. | -9.4% | tweet ↗ |
| 2026-10-15 | @fj_nextstage | +0.25 | Reports additions to the IBD 50 during a defensive portfolio reshuffle. | -11.1% | tweet ↗ |
| 2026-10-15 | @ClassicRoy | +0.00 | Explicit watchlist without entry intent or stated direction. | -11.1% | tweet ↗ |
| 2026-10-15 | @OpenOutcrier | +0.35 | Dexcom study was published in NEJM with claimed standard-of-care implications. | -11.1% | tweet ↗ |
| 2026-10-15 | @Briefingcom | +0.40 | Published CONNECT trial data showed G7 reduced A1C by 1.6% and added five daily target-range hours. | -11.1% | tweet ↗ |
| 2026-10-15 | @Briefingcom | +0.03 | Premarket gap list reports percentage moves for several stocks. | -11.1% | tweet ↗ |
| 2026-10-12 | @KeithTradeSmith | +0.50 | Presents healthcare names as decade-long beneficiaries of aging and chronic-disease demand. | -9.3% | tweet ↗ |
| 2026-10-06 | @AryaFintech | -0.30 | Lists the five largest S&P 500 decliners with their daily percentage losses. | -6.5% | tweet ↗ |
| 2026-10-06 | @InvestVerified | +0.65 | Buy DXCM at $82.50 near double support. — States a concrete DXCM buy level at double support. | -6.5% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.